Difficulty: Medium
Average Score: 95%
Practice
The nurse is reviewing the procedure for alpha-fetoprotein (AFP) screening with a patient at 16 weeksÔÇÖ gestation. What sample will be collected for the initial screening process?
Correct answer
B
Rationale
In the context of advanced maternal age monitoring, it is essential for nurses to have a strong understanding of the procedures involved in prenatal screening, such as alpha-fetoprotein (AFP) screening. The correct answer to the question is B) Blood.
The rationale for this choice is that alpha-fetoprotein (AFP) screening, which is typically done around 16 weeks of gestation, involves measuring the levels of AFP in the maternal blood. Elevated AFP levels can indicate a higher risk of certain fetal abnormalities, such as neural tube defects. Therefore, collecting a blood sample is crucial for this screening process as it allows for the accurate measurement of AFP levels.
Regarding why the other options are incorrect:
A) Urine: Urine is not the appropriate sample for AFP screening as the levels of AFP are measured in the blood, not in the urine. Using urine would not provide accurate information for this specific screening test.
C) Saliva: Similarly, saliva is not used for AFP screening. The levels of AFP need to be measured in the bloodstream to provide meaningful information about the risk of fetal abnormalities.
D) Amniotic fluid: While amniotic fluid can be used for certain prenatal tests like amniocentesis, it is not the sample collected for AFP screening. AFP screening is a non-invasive blood test that does not require the collection of amniotic fluid.
Educational context: Understanding the rationale behind the choice of sample for AFP screening is crucial for nurses working in prenatal care. By knowing why blood is the appropriate sample, nurses can confidently explain the procedure to patients, interpret test results accurately, and provide appropriate support and education based on the findings. This knowledge enhances the quality of care provided to pregnant women, especially those of advanced maternal age who may require additional monitoring and screening.
The rationale for this choice is that alpha-fetoprotein (AFP) screening, which is typically done around 16 weeks of gestation, involves measuring the levels of AFP in the maternal blood. Elevated AFP levels can indicate a higher risk of certain fetal abnormalities, such as neural tube defects. Therefore, collecting a blood sample is crucial for this screening process as it allows for the accurate measurement of AFP levels.
Regarding why the other options are incorrect:
A) Urine: Urine is not the appropriate sample for AFP screening as the levels of AFP are measured in the blood, not in the urine. Using urine would not provide accurate information for this specific screening test.
C) Saliva: Similarly, saliva is not used for AFP screening. The levels of AFP need to be measured in the bloodstream to provide meaningful information about the risk of fetal abnormalities.
D) Amniotic fluid: While amniotic fluid can be used for certain prenatal tests like amniocentesis, it is not the sample collected for AFP screening. AFP screening is a non-invasive blood test that does not require the collection of amniotic fluid.
Educational context: Understanding the rationale behind the choice of sample for AFP screening is crucial for nurses working in prenatal care. By knowing why blood is the appropriate sample, nurses can confidently explain the procedure to patients, interpret test results accurately, and provide appropriate support and education based on the findings. This knowledge enhances the quality of care provided to pregnant women, especially those of advanced maternal age who may require additional monitoring and screening.